By Tony Fong

NEW YORK (GenomeWeb News) – Synpromics, which is developing synthetic promoters for applications in diagnostics development, gene therapeutics, and research use, has launched.

The company is currently in discussions with several life science vendors and gene therapeutics firms to codevelop and comarket the promoters, Michael Roberts, its founder and managing director, told GenomeWeb Daily News.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.